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Autism is a common neurodevelopmental disorder with a significant genetic component. Existing research suggests
that multiple genes contribute to autism and that epigenetic effects or gene-gene interactions are likely contributors
to autism risk. However, these effects have not yet been identified. Gamma-aminobutyric acid (GABA), the primary
inhibitory neurotransmitter in the adult brain, has been implicated in autism etiology. Fourteen known autosomal
GABA receptor subunit genes were studied to look for the genes associated with autism and their possible inter-
actions. Single-nucleotide polymorphisms (SNPs) were screened in the following genes: GABRG1, GABRA2,
GABRA4, and GABRB1 on chromosome 4p12; GABRB2, GABRA6, GABRA1, GABRG2, and GABRP on 5q34-
q35.1; GABRR1 and GABRR2 on 6q15; and GABRA5, GABRB3, and GABRG3 on 15q12. Intronic and/or silent
mutation SNPs within each gene were analyzed in 470 white families with autism. Initially, SNPs were used in a
family-based study for allelic association analysis—with the pedigree disequilibrium test and the family-based
association test—and for genotypic and haplotypic association analysis—with the genotype-pedigree disequilibrium
test (geno-PDT), the association in the presence of linkage (APL) test, and the haplotype family-based associa-
tion test. Next, with the use of five refined independent marker sets, extended multifactor-dimensionality reduction
(EMDR) analysis was employed to identify the models with locus joint effects, and interaction was further verified
by conditional logistic regression. Significant allelic association was found for markers RS1912960 (in GABRA4;
P p .01) and HCV9866022 (in GABRR2; P p .04). The geno-PDT found significant genotypic association for
HCV8262334 (in GABRA2), RS1912960 and RS2280073 (in GABRA4), and RS2617503 and RS12187676 (in
GABRB2). Consistent with the allelic and genotypic association results, EMDR confirmed the main effect at
RS1912960 (in GABRA4). EMDR also identified a significant two-locus gene-gene effect model involving
RS1912960 in GABRA4 and RS2351299 in GABRB1. Further support for this two-locus model came from both
the multilocus geno-PDT and the APL test, which indicated a common genotype and haplotype combination
positively associated with disease. Finally, these results were also consistent with the results from the conditional
logistic regression, which confirmed the interaction between GABRA4 and GABRB1 (odds ratiop 2.9 for interaction
term; P p .002). Through the convergence of all analyses, we conclude that GABRA4 is involved in the etiology
of autism and potentially increases autism risk through interaction with GABRB1. These results support the hy-
pothesis that GABA receptor subunit genes are involved in autism, most likely via complex gene-gene interactions.
Introduction
Autistic disorder (MIM 209850) is a neurodevelopmen-
tal disorder characterized by impairments in reciprocal
social interaction and communication and the presence
of restricted and repetitive patterns of interest or be-
havior. These impairments are apparent in the first 3
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years of life and persist into adulthood. With the im-
proved detection and recognition of autism that has re-
sulted from a broadening of the diagnostic concept and
systematic population approaches, a recent prevalence
study reported that autistic disorder affects as many as
1 in 300 children in a U.S. metropolitan area (Yeargin-
Allsopp et al. 2003). The increase in prevalence has
drawn significant attention from scientists, and a rapid
increase in the level of interest in the etiology of autism
has been seen in the past decade (Fombonne 1999,
2003).
Autism has turned out to be one of the most heritable
complex genetic disorders in psychiatry. A strong ge-
netic component in autism is indicated by an increased
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concordance rate in MZ twins (60% and 91% for the
narrow and broad phenotypes, respectively), compared
with that in DZ twins (0% and 10% for the narrow
and broad phenotypes, respectively) (Steffenburg et al.
1989; Bailey et al. 1995), and by a 75-fold greater risk
to siblings of idiopathic cases, in comparison with the
risk to the general population (Bolton et al. 1994). Col-
lectively, these studies suggest that autistic disorder in-
volves multiple variants in multiple unlinked loci that
interact to cause the autism phenotype. In addition to
genetic risk-assessment studies, both direct mapping ap-
proaches (chromosomal methods and linkage and as-
sociation studies) and indirect mapping approaches (the
characterization of disorders that share some of the
symptoms of autism, such as Rett or fragile X syn-
drome) have been applied to identify autism-suscepti-
bility genes. These studies have also yielded convincing
evidence for the multigenic inheritance and the locus or
allelic heterogeneity in autism.
Over 10 genomewide autism screens have been per-
formed (International Molecular Genetic Study of Au-
tism Consortium 1998, 2001; Meyers et al. 1998; Phi-
lippe et al. 1999; Risch et al. 1999; Collaborative
Linkage Study of Autism 2001; Liu et al. 2001; Auranen
et al. 2002; Shao et al. 2002; Yonan et al. 2003). Results
from these various screens indicate potential suscepti-
bility genes spread across the entire genome. Estimates
of the number of genes involved in autism range from
3–10 (Pickles et al. 1995; Folstein and Rosen-Sheidley
2001) to 15 (Risch et al. 1999) to 100 (Pritchard
2001). Numerous association studies of the candidate
genes have been conducted on the basis of location in
a linkage peak or potential function, but no single gene
has been consistently replicated across studies. One
explanation for the lack of consistency in association
studies is that there are many contributing genetic and
environmental factors in autism. Moreover, multiple in-
teracting genes may be the main causative determinants
of autism (Muhle et al. 2004; Veenstra-VanderWeele et
al. 2004). With only a modest sample size, a small-to-
moderate locus effect is not easily detected. Therefore,
tests for joint effects may be more successful in the
search for autism-susceptibility genes.
Several lines of research indicate that there are ab-
normalities in the gamma-aminobutyric acid (GABA)
system that may lead to developmental changes similar
to those observed in autism. The evidence implicates
GABA receptor (GABAR) subunit genes as functional
candidates for autism (Blatt et al. 2001; Hussman 2001;
Aldred et al. 2003). GABA acts on the GABAR complex,
a heteromeric structure, and mediates synaptic inhibi-
tion in the adult brain (Hahn et al. 2003; Moore 2003).
During development, GABA also acts as an excitatory
neurotransmitter because of the high intracellular chlo-
ride concentration in immature neurons (Jentsch et al.
2002). Eight GABA classes (a, b, d, , g, p, v, and r)
and 18 receptor subunit genes have been characterized
in mammals. In addition to providing binding sites for
GABA, the GABAR contains sites for several therapeu-
tic agents, including benzodiazepines, barbiturates, an-
esthetics, and alcohols. Binding studies that used labeled
ligands in children indicate that GABAR density is
greater early in life and then dramatically decreases to
adult levels (Chugani et al. 2001). Subunit composi-
tion varies developmentally and across brain structure.
It is notable that the studies found a significant decrease
in GABAR density in autism (Blatt et al. 2001) and an
elevated plasma GABA level in autistic children (Dhos-
sche et al. 2002).
The most promising region identified by autism as-
sociation studies is on chromosome 15q12, which har-
bors a set of three GABAR subunit genes (Cook et al.
1998; Martin et al. 2000a; Wolpert et al. 2000; Boyar
et al. 2001; Menold et al. 2001; Buxbaum et al. 2002).
Chromosome 15q11-q13 duplications and deletions
have also been documented in children with autism
(Bundey et al. 1994; Smith et al. 2000; Pujana et al.
2002). In addition, several groups have identified this
region as an area of interest through linkage studies
(Philippe et al. 1999; Liu et al. 2001). Follow-up fine
mapping narrowed this 15q region to the GABRB3 gene
by use of a phenotypic subtype defined by a high degree
of insistence on sameness (Shao et al. 2003). All of these
findings from direct or indirect mapping studies strongly
suggest that the GABAR subunit genes may play an
important role, both independently and interactively, in
the etiology of autism.
Epistasis or gene-gene interaction has been widely ac-
cepted as an important contributor to the complexity
of mapping complex disease genes (Moore 2003). The
failure to replicate some single-locus results might be
the result of an underlying genetic architecture in which
gene-gene interactions are the norm rather than the ex-
ception (Moore and Williams 2002). Thus, genetic stud-
ies that ignore epistasis or gene-gene interactions are
likely to reveal only part of the genetic architecture.
Although the term “epistasis” was initially used by Wil-
liam Bateson early in the 20th century to describe the
reason for distortions of Mendelian segregation ratios
and was later defined by Fisher as deviation from ad-
ditivity in a linear statistical model (Moore 2005), the
methodology for testing epistasis or gene-gene inter-
action is still in its infancy. The available methods have
been thoroughly reviewed recently (Thornton-Wells et
al. 2004). In general, a lack of powerful statistical meth-
ods and large sample sizes limits the identification and
characterization of gene-gene interactions (Moore and
Williams 2002). The main issues confronted by tradi-
tional methods, such as logistic regression, are insuffi-
cient power and flexibility to detect high-order gene-
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Table 1
The PDT and geno-PDT Association Analyses
of GABA Genes and Autism
CHROMOSOME,
GENE, AND SNP
MARKER
NUMBER
GLOBAL P FORa
PDTb geno-PDTc
Chromosome 4:
GABRG1:
RS1497571 1 .899 .906
RS2350439 2 .509 .717
RS1826923 3 .340 .622
GABRA2:
HCV7537166 4 .556 .778
RS279858 5 .361 .623
RS279844 6 .138 .294
HCV8262290 7 .064 .141
RS4695152 8 .508 .730
HCV8262334 9 .149 .033
GABRA4:
RS7678338 10 .737 .936
RS1512136 11 .935 .996
HCV1592545 12 1.000 .968
RS1912960 13 .012 .003
RS2280073 14 .072 .034
RS10517174 15 .738 .142
RS3792211 16 .677 .391
GABRB1:
RS2351299 17 .817 .098
RS1372496 18 .088 .160
RS3114084 19 .180 .317
HCV11353524 20 .115 .243
HCV2119841 21 .906 .432
RS6289 22 .544 .276
RS6290 23 .940 .506
Chromosome 5:
GABRB2:
RS253017 24 .774 .317
RS252965 25 .649 .299
RS2617503 26 .108 .025
RS2962425 27 .367 .443
RS2962407 28 .771 .149
RS12187676 29 .407 .015
GABRA6:
RS3811995 30 .613 .488
RS6883829 31 .932 .236
HCV164095 32 .814 .920
RS3811991 33 .652 .283
GABRA1:
RS4340950 34 .426 .650
HCV11258504 35 .633 .601
RS6878494 36 .395 .699
HCV1667770 37 .861 .522
HCV11814555 38 .294 .576
GABRG2:
RS7728001 39 .670 .833
RS766349 40 .700 .223
RS211014 41 .655 .815
GABRP:
HCV3165046 42 .872 .779
RS1812910 43 .965 .981
RS1862242 44 .347 .593
RS1063310 45 .560 .807
(continued)
Table 1 (continued)
CHROMOSOME,
GENE, AND SNP
MARKER
NUMBER
GLOBAL P FORa
PDTb geno-PDTc
Chromosome 6:
GABRR1:
RS404943 46 .619 .674
RS407206 47 .623 .835
RS423463 48 .475 .718
RS3777530 49 .644 .831
RS2297389 50 .851 .150
RS881293 51 .832 .978
RS6902106 52 .829 .712
GABRR2:
RS282117 53 .277 .494
HCV9866022 54 .064 .171
RS2148174 55 .855 .770
HCV9865968 56 .780 .962
Chromosome 15:
GABRB3:
RS2081648 57 .602 .837
RS1426217 58 .191 .305
RS754185 59 .672 .852
HCV8865209 60 .337 .521
RS2059574 61 .304 .405
GABRA5:
HCV42974 62 .646 .072
RS7173260 63 .938 .845
RS140681 64 .886 .762
RS140683 65 .825 .978
GABRG3:
HCV2078506 66 .079 .240
RS208129 67 .281 .266
RS897173 68 .240 .451
HCV428306 69 1.000 .611
RS140679 70 .410 .589
a P values !.05 are shown in bold italics.
b P values adjusted for two alleles.
c P values adjusted for three genotypes.
gene interactions. Several newly developed methods,
such as the multilocus genotype-pedigree disequilib-
rium test (geno-PDT) (Martin et al. 2003a) and the
multifactor-dimensionality reduction (MDR) method
(Ritchie et al. 2001), improve the ability to identify the
high-order gene-gene interactions with the use of rela-
tively small sample sizes. However, the methods have
difficulty in distinguishing true interactive effects from
joint effects. With the data-driven analytic methods that
are continually in development to examine complex ge-
netic interactions, it has become increasingly important
to emphasize model validation to ensure that significant
effects represent true relationships rather than chance
findings (Coffey et al. 2004). Thus, a multianalytic ap-
proach to the analysis of gene-gene interactions was
proposed (Ashley-Koch et al. 2004), an approach that
searches for consistency of results and preponderance
of evidence to draw the most useful conclusions. In the
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Table 2
Best Gene-Gene Effect Models Identified by EMDR for GABAR Subunit Genes
on Chromosome 4
GENE
AND MARKER
MARKER
NUMBER LOCATION
BEST
MODEL
NONFIXED P VALUEa
x2 Misclassification
GABRG1:
RS1497571 1 65.47 9 .06 .038
RS2350439 2 65.49 9, 13 .004 .002b
GABRA2: 2, 9, 15 .016 .03
RS279858 3 65.66 2, 7, 9, 15 .16 .33
RS279844 4 65.66
HCV8262290 5 65.67
RS4695152 6 65.68
HCV8262334 7 65.68
GABRA4:
HCV1592545 8 65.85
RS1912960 9 65.86
RS2280073 10 65.86
RS10517174 11 65.87
RS3792211 12 65.87
GABRB1:
RS2351299 13 65.92
RS1372496 14 65.94
RS3114084 15 65.95
HCV11353524 16 65.97
HCV2119841 17 65.99
RS6289 18 66.00
RS6290 19 66.00
a Empirical P value derived from nonfixed permutation test by use of x2 or the
misclassification rate as the test statistic in EMDR.
b The locus with the lowest P value (in bold italics) was selected as the one for the
final cross-chromosome model.
current study, this new paradigm was applied to test
our hypothesis that GABAR subunit genes may con-
tribute to the etiology of autism independently and/or
through complex interactions between subunit genes.
Families and Methods
Family Ascertainment
A standard ascertainment protocol was conducted by
the clinical groups at the Duke Center for Human Ge-
netics and the William S. Hall Psychiatric Institute. Both
sites recruited, enrolled, and sampled individuals with
autism and family members per study protocols ap-
proved by their respective institutional review boards
(IRBs). Participating families were ascertained using clin-
ical referrals and active recruitment through lay orga-
nizations that provide services to families with autism.
After a full description of the study was given to the
families, written informed consent was obtained from
parents and from children who were able to give in-
formed consent. For the current study, a total of 470
white families were included, of which 266 were mul-
tiplex (i.e., more than one affected individual sampled)
and 204 were triads (i.e., only one affected individual
sampled). The Collaborative Autism Team from the
Duke Center for Human Genetics and the William S.
Hall Psychiatric Institute contributed 246 families, and
224 families were from the Autism Genetic Resource
Exchange. Probands for the study consisted of individ-
uals between the ages of 3 years and 21 years who re-
ceived a clinical diagnosis of autism by use of DSM-IV
criteria. A consistent set of diagnostic criteria was ap-
plied to all families. Qualified individuals and families
were those who met best-estimate clinical research di-
agnoses for autism, as determined by the lead clinicians
(H.H.W. and M.L.C.) at each of the research sites. The
best-estimate diagnoses were made using all available
case material, including clinical records, Autism Diag-
nostic Interview–Revised (ADI-R) results, and clinical
assessment information. All qualified individuals met
current DSM-IV diagnostic criteria for autism. The ADI-
R (Lord et al. 1997) is a validated, semistructured di-
agnostic interview, which yields a diagnostic algorithm
based on the DSM-IV criteria for autism. All ADI-R
interviews were conducted by formally trained inter-
viewers who have established reliability within our
group as well as within Dr. Lord’s group. Finally, all
participants who met current diagnostic criteria for au-
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Table 3
Best Gene-Gene Effect Models Identified by EMDR for GABAR Subunit Genes
on Chromosome 5
GENES
AND MARKER
MARKER
NUMBER LOCATION BEST MODEL
NONFIXED P VALUEa
x2 Misclassification
GABRB2:
RS253017 1 165.09 6 .412 .282b
RS252965 2 165.09 3, 6 .657 .762
RS2617503 3 165.098 4, 8, 18 .710 .551
RS2962425 4 165.155 3, 10, 13, 17 .810 .800
RS2962407 5 165.203
RS12187676 6 165.246
GABRA6:
HCV164095 7 165.362
RS3811991 8 165.364
GABRA1:
RS4340950 9 165.476
RS6878494 10 165.494
HCV1667770 11 165.502
HCV11814555 12 165.505
GABRG2:
RS169793 13 165.667
RS7728001 14 165.674
RS766349 15 165.677
RS211014 16 165.693
GABRP:
HCV3165046 17 182.846
RS1812910 18 182.859
RS1862242 19 182.871
RS1063310 20 182.877
a Empirical P value derived from nonfixed permutation test by use of x2 or the mis-
classification rate as the test statistic in EMDR.
b The locus with the lowest P value (in bold italics) was selected as the one for the
final cross-chromosome model.
tism were included only if they had a minimal devel-
opmental level of 18 mo for the Vineland Adaptive Be-
havior Scale score (Sparrow et al. 1984) or had an IQ
equivalent 135. These minimal developmental levels as-
sure that ADI-R results are valid and reduce the likeli-
hood of including individuals with severe mental retar-
dation only. Subjects were excluded if they had evi-
dence of developmental disorders with known pheno-
typic overlap with autism (e.g., Prader-Willi syndrome,
Angelman syndrome, tuberous sclerosis complex, Rett
syndrome, and fragile X syndrome), neurologic disor-
ders, or severe sensory or motor disorders.
Genotyping
Blood was obtained from patients and other family
members in accordance with IRB-approved procedures.
DNA was extracted from whole blood by use of stan-
dard protocols (Vance 1998). Analysis of the candidate
region was performed using data obtained from SNPs.
SNPs located within the GABAR subunit genes across
chromosomes were analyzed. Between three and seven
intronic and silent mutation SNPs within each gene were
identified with Applied Biosystems (ABI) Assay-on-De-
mand products. The selected GABAR subunit genes were
GABRG1 (3 SNPs typed), GABRA2 (6), GABRA4 (7),
and GABRB1 (7) on 4p12; GABRB2 (6), GABRA6 (4),
GABRA1 (5), GABRG2 (3), and GABRP (4) on 5q34-
q35.1; GABRR1 (7) and GABRR2 (4) on 6q15; and
GABRB3 (5), GABRA5 (4), and GABRG3 (5) on 15q12.
SNPs were identified from the National Center for Bio-
technology Information SNP database (see dbSNP Web
site) and were ordered for use in either Assays-on-De-
mand or Assays-by-Design (ABI). All SNPs were geno-
typed using TaqMan. All reactions contained 2.7 ng of
total genomic DNA and were run on ABI 9700 Gene-
Amp PCR systems in accordance with the manufac-
turer’s instructions. Analysis of the SNP genotypes was
performed using an ABI Prism 7900HT Sequence De-
tection System.
For quality control (QC) procedures, two CEPH stan-
dards were included on each 96-well plate, and samples
from six individuals were duplicated across all plates as
QCs, with the laboratory technicians blinded to their
identities. Analysis required that identical QC samples
within and across plates have matching genotypes, to
identify errors in loading and reading and thus to min-
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Table 4
Best Gene-Gene Effect Models Identified by EMDR for GABAR Subunit Genes
on Chromosome 6
GENES
AND MARKER
MARKER
NUMBER LOCATION
BEST
MODEL
NONFIXED P VALUEa
x2 Misclassification
GABRR1:
RS404943 1 94.926 8 .644 .587
RS407206 2 94.935 5, 11 .579 .452
RS423463 3 94.946 2, 8, 10 .398 .246b
RS3777530 4 94.975 7, 8, 10, 11 .645 .665
RS2297389 5 94.991
RS881293 6 94.998
RS6902106 7 95.019
GABRR2:
RS282117 8 95.171
HCV9866022 9 95.208
RS2148174 10 95.238
HCV9865968 11 95.277
a Empirical P value derived from nonfixed permutation test by use of x2 or the
misclassification rate as the test statistic in EMDR.
b The locus with the lowest P value (in bold italics) was selected as the one for the
final cross-chromosome model.
imize the error rate in genotype assignments. Meanwhile,
a 95% efficiency of genotype is required. Technicians
generating the genotypic data were blinded to the clinical
status of the patients. After QC verification, genotypes
of the samples were uploaded into the PEDIGENE da-
tabase and were merged into the LAPIS management
system for creation of analysis input files (Haynes et al.
1995).
Statistical Analysis
To further check for genotyping error, the program
PedCheck was run for detection of Mendelian inher-
itance inconsistency. The error checking option embed-
ded in Merlin (Abecasis et al. 2002) was run to identify
the samples with excess recombinations, and the families
were checked further for possible genotyping errors. One
affected and one unaffected individual were selected ran-
domly from each family for tests of Hardy-Weinberg
equilibrium (HWE), which was assessed using exact
tests implemented in the Genetic Data Analysis pro-
gram (Zaykin et al. 1995). For SNPs found to be not
in HWE in the unaffected sample, a sequence of samples
at that particular SNP was required to ensure the quality
of the SNPs. Pairwise linkage disequilibrium (LD) (D′
and r2) between markers was calculated using the GOLD
software package (Abecasis and Cookson 2000). The
allelic association analyses were conducted using the
pedigree disequilibrium test (PDT) (Martin et al. 2000b)
and the family-based association test (FBAT) (Horvath
et al. 2004). These two tests are similar in many aspects,
but each has distinct advantages. The PDT has the ad-
vantage of being valid as a test of both linkage and
association in extended pedigrees, whereas the FBAT
treats nuclear families within large pedigrees as inde-
pendent but permits haplotype-based association tests.
Both PDT and FBAT are allele-based tests. The geno-
PDT (Martin et al. 2003a) is an extension of PDT used
to examine the association between marker genotype
and disease. The haplotype family-based association test
(HBAT) (Horvath et al. 2004) was used for haplotype
association analysis for SNPs within each GABAR sub-
unit gene. Tagging SNPs within each gene were selected
by use of the confidence-interval function in Haploview
(Barrett et al. 2005). Both haplotype-specific P values
and global P values (with adjustment for all possible
haplotypes) were calculated by the program.
The core program of MDR (Ritchie et al. 2001; Hahn
et al. 2003) was employed in this study to test for po-
tential gene-gene interaction and thereby to identify spe-
cific locus combinations of interest for further investi-
gation and replication. Some new features were added
to MDR through the extended MDR (EMDR) (Mei et
al., in press). Basically, EMDR uses the same algorithm
as the core MDR program, a data reduction program
that tests for interactions (Ritchie et al. 2001; Hahn et
al. 2003). EMDR contains several new features. Briefly,
these are (1) allowance of missing data in individuals
with partial genotype data, (2) use of a x2 statistic in
addition to the prediction error as a test statistic, and
(3) introduction and implementation of a nonfixed per-
mutation test to assess the statistical significance of mod-
els identified by EMDR. This nonfixed permutation gen-
erates an empirical P value for a particular n-locus
model, with consideration of all combinations of n loci.
For example, for a particular 2-locus combination, the
nonfixed permutation test accounts for the search of all
possible 2-locus models to decide whether the best model
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Table 5
Best Gene-Gene Effect Models Identified by EMDR for GABAR Subunit Genes
on Chromosome 15
GENE
AND MARKER
MARKER
NUMBER LOCATION
BEST
MODEL
NONFIXED P VALUEa
x2 Misclassification
GABRB3:
RS2081648 1 11.07 10 .219b .706
RS1426217 2 11.08 5, 10 .494 .56
RS754185 3 11.23 4, 10, 13 .843 .85
HCV8865209 4 11.33 4, 5, 10, 13 .623 .875
RS2059574 5 11.54
GABRA5:
HCV42974 6 12.06
RS140681 7 12.12
RS140683 8 12.14
GABRG3:
HCV2078506 9 12.38
RS208129 10 12.81
RS897173 11 12.94
HCV428306 12 14.46
RS140679 13 14.66
a Empirical P value derived from nonfixed permutation test by use of x2 or the
misclassification rate as the test statistic in EMDR.
b The locus with the lowest P value (in bold italics) was selected as the one for the
final cross-chromosome model.
is significant. An empirical P value !.05 was regarded
as statistically significant and is inherently adjusted for
multiple testing. In this study, a cross-validation option
was not used.
For case-control pairs used in EMDR, the proband
(or the most completely genotyped affected child) from
each multiplex and triad family was selected ( ),np 470
and the untransmitted alleles were generated using pa-
rental genotypes as a control. Given the sample size of
470 case-control pairs in this study, we did not test for
interactions that were 14-way interactions (Mei et al.,
in press).
Independent markers (tagging SNPs) were used in
four chromosome-by-chromosome models and were se-
lected using the confidence-interval function in Haplo-
view (Barrett et al. 2005). Meanwhile, to retain adequate
power to detect a gene-gene effect, the markers with the
smallest P values from the four by-chromosome models
were selected to build the final cross-chromosome model.
The reason for the selection is that the permutation test
inherently adjusts for multiple comparisons, and true
effects can be overwhelmed when many markers are con-
sidered. Therefore, to maintain reasonable power, we
judiciously chose a relatively small subset of markers for
the MDR analysis. Our approach was staged so that
each chromosome was examined and the markers having
the smallest P values within each chromosome were se-
lected for the overall analysis.
The significant best models identified by EMDR can
only suggest a gene-gene effect, rather than a certain
interaction. This holds true especially if a particular lo-
cus in a significant n-locus model also presents a signif-
icant main effect as the best 1-locus model. In this case,
the identified gene-gene effect may be driven by the main
effect from the locus, rather than by a true interaction.
To verify the interaction between genes in the identified
model, conditional logistic regression (by use of COX-
REG in SPSS, version 11.5 for Windows) was performed.
To test for interaction, all variables (i.e., markers in the
identified model) and their interaction terms were forced
into the model. The genotypes of the markers were re-
coded in the logistic regression analysis. Genotypes with
a case:control ratio 11 were collapsed and were recoded
as the high-risk group, and those with a ratio !1 were
recoded as the low-risk group. This matched the di-
mensionality-reduction strategy applied in EMDR, en-
abling consistent interpretation of the results between
EMDR and the logistic regression analysis. In this stu-
dy, GG was coded as a high-risk group for marker
RS1912960, and GG and TT were coded as high-risk
groups for RS2351299. Finally, multilocus geno-PDT
and association in the presence of linkage (APL) analysis
(Martin et al. 2003b) were used to validate the gene-
gene interaction from the logistic regression.
Results
No significant deviation from HWE was found in un-
affected whites for all SNPs. SNP RS1426217 (in
GABRB3) on chromosome 15 presented evidence of de-
viation from HWE in the affected individuals (Pp
). PDT showed that RS1912960 (in GABRA4) on.019
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Table 6
Best Gene-Gene Effect Models Identified by EMDR for All Known Autosomal GABAR Subunit Genes
MARKER GENE LOCATION CHROMOSOME
MARKER
NUMBER
SNP
NUMBER
BEST
MODEL
NONFIXED P VALUEa
x2 Misclassification
RS1912960 GABRA4 65.857 4 9 1 1 .035 .02
RS2351299 GABRB1 65.916 4 13 2 1, 2 .002 .001
RS12187676 GABRB2 165.246 5 6 3 5, 6, 7 .009 .008
RS407206 GABRR1 94.935 6 2 4
RS282117 GABRR2 95.171 6 8 5
RS2148174 GABRR2 95.238 6 10 6
RS208129 GABRG3 12.813 15 10 7
a Empirical P value derived from nonfixed permutation test by use of x2 or the misclassification rate as the test statistic
in EMDR.
Table 7
Results for Multilocus geno-PDT
for Two Loci on Chromosome 4
GENOTYPEa
RS1912960 RS2351299 P VALUEb
1,1 1,1 .015
1,1 1,2 .330
1,1 2,2 .096
1,2 1,1 .061
1,2 1,2 .635
1,2 2,2 .835
2,2 1,1 .001
2,2 1,2 .046
2,2 2,2 .386
a For RS1912960, 1 p C; 2 p G
(common allele); for RS2351299, 1 p
G (common allele); 2 p T.
b P value for each genotype combi-
nation. The global P value (after adjust-
ment for all possible genotype combi-
nations) is .0007.
chromosome 4 had a preferential transmission of the
common G allele to the affected offspring ( )Pp .012
(table 1). In addition, FBAT identified a significant as-
sociation at HCV9866022 (in GABRR2) on chromo-
some 6 ( ), where the PDT results suggested aPp .04
similar trend ( ) (the entire FBAT data are notPp .064
shown; results were similar to those of PDT). The geno-
PDT displayed positive genotype association on chro-
mosome 4 for homozygous common genotypes TT, GG,
and GG at HCV8262334 (in GABRA2), RS1912960
(in GABRA4), and RS2280073 (in GABRA4), respec-
tively, and, on chromosome 5, for heterozygous geno-
types CT and CG in RS2617503 and RS12187676 (both
in GABRB2), respectively (global P values given in table
1). SNPs on the same chromosome did not show LD
with each other (LD data not shown).
Haplotype analysis was performed using tagging
SNPs within each gene, and it confirmed significant as-
sociation with autism for specific haplotypes with-
in GABRA2 ( ), GABRA4 ( ), andPp .027 Pp .025
GABRR2 ( ). However, the global P value wasPp .028
not significant ( ) for any of the genes tested.P 1 .05
To test for a gene-gene effect, EMDR was run for by-
chromosome and cross-chromosome models. Of all of
the by-chromosome models tested (tables 2–6), two sig-
nificant models were found on chromosome 4. There is
a 2-locus model involving RS1912960 in GABRA4 and
RS2351299 in GABRB1 ( ) and a 3-locusPp .002
model involving RS2350439 in GABRG1, RS1912960
in GABRA4, and RS3114084 in GABRB1 ( ),Pp .03
which suggests a potential gene-gene interaction among
GABRG1, GABRA4, and GABRB1 (table 2). (The
original MDR under the 10-fold cross-validation op-
tion was run, and it confirmed a potential gene-gene
effect in a 2-locus model [prediction error p 43%;
].) In the cross-chromosome model (table 6),Pp .023
EMDR identified the same best 1-locus and 2-locus
( ) models as in the by-chromosome modelPp .001
for chromosome 4 and confirmed the main effect at
RS1912960 (in GABRA4; ). Another 3-locusPp .02
model (RS282117 and RS2148174 in GABRR2 and
RS208129 in GABRG3; ) was also identified,Pp .008
suggesting a potential gene-gene interaction across chro-
mosomes, between GABRR2 (chromosome 6) and
GABRG3 (chromosome 15).
To evaluate whether the joint effects identified by the
EMDR are the result of interacting genes, conditional
logistic regression was conducted; the results supported
a significant 2-locus gene-gene interaction between GA-
BRA4 and GABRB1 (odds ratio [OR] of 2.9 for inter-
action term, high risk vs. low risk; ) but didPp .002
not detect an interaction in the cross-chromosome 3-
locus or chromosome 4 3-locus model.
Consistent with the interaction term in the logistic
regression described above (high risk [GG] and high risk
[GGTT] combination), multilocus geno-PDT (table 7)
supported a positive cross-marker genotype association
with disease between two common variant genotypes
at RS1912960 (GG) and RS2351299 (GG). The APL
analysis confirmed a positive association of the G allele
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at RS1912960 ( ) and also presented a posi-Pp .031
tive haplotype association with disease for a haplotype
with two common variants (G-G) (RS1912960 and
RS2351299; ; global ), which indi-Pp .014 Pp .014
rectly supported the genotype association shown by
EMDR.
Discussion
This is, to our knowledge, the first comprehensive in-
vestigation of the allelic, genotypic, and haplotypic as-
sociation together with an investigation of potential
gene-gene interactions of all known autosomal GABAR
subunit genes with autism. These novel findings indicate
that GABRA4 is involved in the etiology of autism, both
independently and through interaction with GABRA1.
These data support the hypothesis that complex inter-
actions account for autism risk and present some of the
first evidence for it.
In the present study, several approaches were used to
control for false-positive results and thus to protect
against incorrect conclusions regarding the etiology
of the disease. First, we included only autism-affected
white families in the analysis, to avoid biased results
due to population stratification. Second, all GABA genes
selected have a substantial a priori probability of in-
volvement in autism (Sullivan et al. 2001). Finally, we
used a multianalytic approach, as described elsewhere
(Ashley-Koch et al. 2004), to interpret our findings. This
approach looked for the convergence of results across
several methods, rather than relying on results from
a single analytic tool. Specifically, several approaches
were applied to validate the interaction identified by
EMDR, including conditional logistic regression.
To evaluate multilocus effects in a comprehensive
way, the results from allelic, genotypic, and haplotypic
analyses were integrated for a best estimate. We also
used an extended version of MDR (Mei et al., in press),
in which several modifications were made to MDR, in-
cluding allowance for missing data, improved estima-
tion of test statistic distribution, and more-accurate ad-
justment of multiple testing. These new features in
EMDR have been validated elsewhere (Mei et al., in
press). In this study, we chose to use the no-cross val-
idation option and to omit the 10-fold cross-validation
in each run. This option has shown lower false-positive
and false-negative rates than the original MDR (Mei et
al., in press).
We previously reported linkage and weak association
for SNPs in the cluster GABAR region on chromosome
15q in our autism data set (Bass et al. 2000; Martin et
al. 2000a; Menold et al. 2001; Shao et al. 2003). One
possible explanation for this finding would be that there
are multiple disease variants for autism risk in this re-
gion and that any one variant is only weakly associated
with an individual haplotype. Similarly, the present
study did not find association for a single locus in this
region. However, RS1426217, which is located in intron
6 of GABAB3, significantly deviated from HWE only
in affected individuals. This does not invalidate the as-
sociation analysis, since both PDT and FBAT do not
require HWE. It has been suggested elsewhere that ab-
sence of HWE may be an indication of the presence of
association of a susceptibility allele that is in LD with
the tested SNP (Nielsen et al. 1998). Thus, this finding
might suggest that RS1426217 is in LD with a nearby
disease allele. Extending the analysis to chromosome 15
GABAR genes (GABRB3, GABRA5, and GABRG3),
we applied a similar genetic analysis paradigm (Ashley-
Koch et al. 2004) to look for interactions among these
three genes to determine whether these interactions
contribute to risk, but no multilocus effects were de-
tected. In a cross-chromosome model, however, we did
find a joint effect between GABRR2 (chromosome 6)
and GABRG3 (chromosome 15), although conditional
logistic regression failed to confirm this interaction. On
the basis of the FBAT and HBAT results for GABRR2,
this joint effect is most likely driven by the effect from
GABRR2 only. Even so, the finding merits further in-
vestigation in a larger and/or independent sample.
The most promising finding in this study was the
significant allelic and genotypic association that was
found at RS1912960 (in GABRA4), both from the com-
mon variant G and the common genotype GG. Also,
the HBAT identified a significant haplotype within GA-
BRA4, although the global P value showed only mar-
ginal significance ( ). Moreover, the associationPp .06
remained significant even after adjustment for multiple
testing in EMDR. The program generates 1,000 simu-
lated data sets by permuting the status of cases and
controls to obtain an empirical P value for the marker
while testing the significance for the 1-locus best model.
RS1912960 remained the best 1-locus model in both
the by-chromosome and the cross-chromosome models.
The empirical P value for this marker was .038 for the
by-chromosome model and .020 for the cross-chromo-
some model. Thus, this significant association appeared
to be consistent across all analyses, which strongly sug-
gests that GABRA4 is involved in the etiology of autism.
Although no strong linkage or significant associa-
tion at GABRA4 had previously been reported, two
genome screens reported suggestive linkage at 4p (In-
ternational Molecular Genetic Study of Autism Con-
sortium 1998; Auranen et al. 2000). Two chromosomal
studies indicated abnormality in the 4p12 region, which
is at the same location as GABRA4: a British group
reported a 46,XX, dup (4) p12-p13 chromosome ab-
normality in an 18-year-old female with autism (Sa-
baratnam et al. 2000), and a Canadian group reported
a paracentric inversion of the short arm of chromosome
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4 (46,XY, inv [4] p12-p15.3) in two brothers with au-
tism (Choufani et al. 2003). Given the convergence of
all available results, we believe the positive association
at RS1912960 (in GABRA4) reflects a true association
with autism.
Relatively little is known about the biological func-
tion(s) of the GABARA4 subunit. Gene expression is
known to be highly variable, depending on brain re-
gion, neuronal activity, and development, which sug-
gests complex regulation and involvement in multiple
brain activities and functions. Levels of a4 mRNA are
found in the hippocampus, the dentate gyrus, the thal-
amus, the nucleus accumbens, the cerebellum, the outer
layers of the cortex, and other regions, and they peak
during development. Unlike most GABAA receptor com-
plexes, those containing a4 are not sensitive to modu-
lation by diazepam. It has been suggested that the a4
subunit may be involved in neuronal hyperexcitability.
The promoter for a4 has multiple transcription initi-
ation sites, and alternate splicing in mouse brain has
been observed (Ma et al. 2004).
We also found a potential interaction between GA-
BRA4 and another clustering GABA gene, GABRB1
( for interaction term). We identified this po-ORp 2.9
tential gene-gene effect model in EMDR from both the
by-chromosome and the cross-chromosome models. In
addition, the interaction was further confirmed by con-
ditional logistic regression, in which two common GG-
GG variant combinations substantially increased autism
risk. This finding is also consistent with the results from
multilocus geno-PDT (GG-GG) and APL haplotype
analysis (G-G). Again, the accumulation of findings
across all analyses leads us to conclude that GABRB1
may be involved through interaction with GABRA4.
In conclusion, this study suggests that the GABRA4
gene is involved in the etiology of autism and substan-
tially increases autism risk through interaction with the
GABRB1 gene. Furthermore, these findings support the
hypothesis that the etiology of autism is complex and
that complex interactions may contribute to autism risk.
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